Loading...
Market
What will be the outcome of Professor Buckhaults' in vivo mRNA vaccine DNA integration research by end of 2024?
2
Resolution / Starting Odds
Proven integration in humans • 25%
No integration found • 25%
Inconclusive results • 25%
Study not completed • 25%
Publication of study results in a peer-reviewed scientific journal
Story
In Vitro Evidence Shows mRNA Vaccine DNA Can Integrate into Human Cells, Prof. Buckhaults Leads In Vivo Research Pending
Nov 25, 2024, 05:17 PM
Recent studies have provided evidence suggesting that plasmid DNA from mRNA vaccines can integrate into human cellular DNA. Findings indicate that genomic integration of plasmid DNA has been demonstrated in vitro, but in vivo studies are still pending. Professor Buckhaults has reportedly shown that plasmid DNA, which can reach human cells through mRNA vaccines, not only enters these cells but can also integrate into their DNA. While some experts claim this integration has now been proven, others caution against mischaracterizing the results as indicative of integration occurring in humans, emphasizing that further clarification is needed. The implications of these findings on public health and societal perceptions remain to be fully understood.
View original story
Similar markets
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
Effective • 25%
Moderately Effective • 25%
Ineffective • 25%
Halted • 25%
Positive • 25%
Negative • 25%
Mixed • 25%
Not published • 25%
Successful • 25%
Partially successful • 25%
Unsuccessful • 25%
No results announced • 25%
Yes • 50%
No • 50%
Successful with no adverse effects • 25%
Successful with minor adverse effects • 25%
Unsuccessful • 25%
Trial halted due to safety concerns • 25%
No issues found • 25%
Minor issues found • 25%
Moderate issues found • 25%
Severe issues found • 25%
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
No change in safety guidelines • 25%
Minor safety warning issued • 25%
Major safety warning issued • 25%
Vaccine approval revoked • 25%
No significant contamination found • 25%
Contamination confirmed, no recall • 25%
Contamination confirmed, recall issued • 25%
Investigation inconclusive • 25%
Successful with significant results • 25%
Moderate success with some positive results • 25%
No significant results • 25%
Trial halted or inconclusive • 25%